| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTI | Common Stock, $0.0001 par value | Sale | -$1.61M | -60K | -22.72% | $26.84 | 204K | Mar 17, 2025 | Direct | F1, F2, F3 |
| transaction | UTI | Common Stock, $0.0001 par value | Sale | -$254K | -9.5K | -4.65% | $26.71 | 195K | Mar 18, 2025 | Direct | F1, F4 |
| transaction | UTI | Common Stock, $0.0001 par value | Sale | -$13.6K | -500 | -0.26% | $27.27 | 194K | Mar 18, 2025 | Direct | F1, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sherrell Smith on December 16, 2024. |
| F2 | This Form 4/A is being filed to correct the reported number of shares sold on March 17, 2025 under the 10b5-1 Plan, as reported on March 19, 2025 (the "Original Form 4"). The Original Form 4 reported that the Reporting Person sold 36,773 shares on March 17, 2025, resulting in the reporting of 227,358 securities beneficially owned in column 5 of the Original Form 4. This Form 4/A corrects the number of shares sold on March 17, 2025 (60,000 shares sold), and the resulting number of securities beneficially owned following such sale (204,131 securities beneficially owned). |
| F3 | The price reported in Column 4 is a weighted average price. Shares were sold in multiple transactions at prices ranging from $26.26 to $27.12, inclusive. Reporting person undertakes to provide to issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth herein. |
| F4 | The prices reported in Column 4 are weighted average prices. Shares were sold in multiple transactions at prices ranging from $26.20 to $27.09, inclusive (weighted average of $26.7107) and $27.21 to $27.36, inclusive (weighted average of $27.2680), respectively. Reporting person undertakes to provide to issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth herein. |